The activist investor claims board members breached their duties in the acquisition of Grail.
Icahn sues to remove Illumina board members, asks for at least $476M in damages Read More »
The private equity firm has nine months to find a buyer for its struggling four-hospital health system under an agreement announced by the Pennsylvania attorney general last week.
Prospect Medical Holdings clear to seek buyer for Crozer Health Read More »
Los mesomorfos son un grupo de personas que han llamado la atención en el mundo del fitness y la fisiología del cuerpo humano. Con una genética privilegiada, estos individuos parecen estar predestinados a desarrollar músculos y fuerza de manera más eficaz que otros …
Mesomorfos: El equilibrio perfecto entre fuerza y estética corporal Read More »
Proscia®, a leading provider of digital and computational pathology solutions, has earned ISO 27001 certification. This certification demonstrates the company’s compliance
Proscia Achieves ISO 27001 Security Certification Read More »
ReAlta Life Sciences, Inc. today announced U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for a Phase 2 clinical trial of RLS-0071 in patients with acute exacerbations of chronic obstructive pulmonary disease (AE-COPD).
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announces a partnership with AbbVie Inc. for the Phase 3 clinical program of upadacitinib (RINVOQ ® ) in individuals living with systemic lupus erythematosus (SLE).
Day Zero Diagnostics Inc. announced today that independent board member, Jeff Mirviss , has been appointed board chair.
Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors Read More »
Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the third quarter ended September 30, 2023.
KalVista Pharmaceuticals, Inc. announced the presentation of a novel analysis characterizing hereditary angioedema attacks occurring in patients receiving long-term prophylaxis treatments at the Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2023 International Conference in Singapore.
Sage Therapeutics, Inc. announced that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.
